Virtual Reality Surgical Planning: AVATAR MEDICAL receives FDA Clearance

On June 8, 2023, AVATAR MEDICAL, a spin-off of the Institut Pasteur and Institut Curie, both granted with the Carnot Label, received 510(k) clearance from the Food and Drug Administration (FDA) for its virtual reality surgical planning solution. AVATAR MEDICAL instantly converts CT scans and MRI images into patient avatars, detailed 3D and virtual reality (VR) representations of the patient's medical images. FDA clearance is a major milestone for this innovative spin-off, which can now market its solution in the United States. CEO Xavier Wartelle expects European certification for 2024.

Find out more